Kenneth Wong, Keen Vision Acquisition chairman and CEO
New SPAC submits plans for $130M IPO, as another raises $60M
Two new biotech SPACs have come to town — and one of them has gone public.
Keen Vision Acquisition Corp. announced its formation via SEC filing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
